Form 4 for AVAH Aveanna Healthcare Holdings, Inc.
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0000899243-23-005329 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-16 | 2023-02-14 | AVAH | Shaner Jeff | CEO | A - Grant | $0.00 | +421.1K | 1.65M | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2023-02-14 | A | A | 421,094 | $0.00 | 1,648,719 | D | — | — | (F1) Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. (F2) Includes (i) 739 shares acquired under Aveanna's Employee Stock Purchase Plan (the "ESPP") on January 4, 2022, (ii) 2,645 shares acquired under the ESPP on July 8, 2022, and (iii) 2,289 shares acquired under the ESPP on January 5, 2023. |